By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


i3 (Basking Ridge, New Jersey) 

131 Morristown Road

Basking Ridge  New Jersey  07920  U.S.A.
Phone: 866-386-3404 Fax: n/a

i3 is a global business providing integrated scientific strategies and solutions throughout the biopharmaceutical product lifecycle. Its unique combination of products, services and knowledge helps companies gain sharper insights that lead to better patient care. i3 consists of:

i3 Research
i3 Research is a full-service contract research organization (CRO) focused on central nervous system, oncology, respiratory and infectious disease, and endocrinology and metabolic disease. Therapeutic specialization drives all aspects of business in this global CRO – from project staffing and talent management to quality initiatives. i3 Research has experience with studies of all sizes—from large multi-national studies to small niche studies. The senior management team is closely involved to make sure customer needs are met or exceeded. A thought leader with a deep understanding in his area of expertise sits at the helm of each therapeutic division to ensure project teams are integrated in that specialized area medically, scientifically, and operationally. The goal is to impel a customer-centric environment while maintaining high levels of talent management.

Additionally, therapeutic leaders engage customers in strategic clinical development of their compounds. They work closely with operational directors, who focus on melding that therapeutic expertise with project execution to develop a unique management strategy for each project. i3 Research’s therapeutic expertise enables project teams to truly understand their subject matter, work more efficiently, anticipate problems, and provide insights that inform client decision-making. This global CRO has capabilities in more than 45 countries, conducting research phases I through IV.

i3 Innovus
i3 Innovus is a leading provider of health economics and outcomes research and market informatics solutions to help clients realize the full potential of their brands. As an international organization that counts among its clients most of the top 20 biopharmaceutical companies in the world, i3 Innovus has a world-class reputation in econometrics and outcomes data analysis and leads the globe in providing research solutions to support market access and reimbursement of health care products. i3 Innovus delivers real-world evidence that demonstrates the value to help products succeed in the market.

    i3 Innovus clients benefit from a diverse expertise of evidenced-based health economics and outcomes methodologies that will help their products gain a competitive advantage. I3 Innovus’ research team includes principal consultants renowned internationally for their development of and contribution to methods of health economic evaluation. Combining that depth of knowledge with i3’s unique capability to conduct sophisticated analyses on its volumes of integrated datasets of information on patient diagnoses, procedures, office visits, hospitalizations, laboratory tests, health care expenditures, and demographics, means i3 Innovus brings its clients unmatched, timely insight and results.

    i3 Innovus’ established relationships with payers, providers, and physicians help clients improve product lifecycle efficiency, resulting in better patient care; its extensive suite of analytic tools leverage its proprietary data assets to deliver up-to-date, meaningful information that supports every aspect of product decision-making. i3 Innovus accesses a proprietary research database that combines de-identified, longitudinal, integrated medical information from 15 million people in any given year, and more than 36 million individuals over the period from 2000 to 2006. i3 Innovus’ products provide clients a better understanding of what’s happening in the market for their product, allowing customers to segment more precisely, measure more appropriately, and grow their brands more effectively with less effort.

    i3 Drug Safety
    i3 Drug Safety provides comprehensive pharmacoepidemiology and pharmacovigilance services. Rooted in scientific rigor, using innovative methods and proven expertise, i3 Drug Safety’s services can be customized for all scopes of work, from safety surveillance and risk assessment in clinical development to post-approval pharmacovigilance.

    i3 Drug Safety’s global team is comprised of respected, published, and specialized researchers—MDs, Pharm Ds, RNs and other specialists—who draw on a combination of deep knowledge of pharmacoepidemiology and pharmacovigilance and access to a proprietary database of the de-identified health experiences of more than 15 million individuals, to deliver high quality research in a timely manner. Clients look to i3 Drug Safety to help identify potential issues, and make smarter decisions earlier.

    i3 Drug Safety works closely with clients to support product safety monitoring and to develop a research strategy that reflects the most in-depth knowledge of a product's potential efficacy. This group of industry thought leaders provides integrated services to support safety throughout the product lifecycle in compliance with FDA and EMEA regulatory requirements for safety surveillance. i3 Drug Safety’s renowned epidemiologists have appeared before these regulatory bodies and scores of professional congresses, and served as key advisors to sponsors, regulators, and payers on how best to meet a product’s safety information needs. Along with hundreds of publications on drug safety to their credit, i3 Drug Safety’s experts are noted for technical expertise, data quality, reliability and transparency.

    i3 Statprobe
    i3 Statprobe focuses exclusively on providing the pharmaceutical and biotechnology industries with comprehensive, integrated data service solutions that include data capture, summary, analysis, and reporting for clinical trials across all phases of research. The company demonstrates leadership and innovation by leveraging world-class process design and six-sigma quality, affording clients the ability to maximize efficiencies and exceed customer expectations.

    Clients look to i3 Statprobe as a strategic vendor whose innovative approach to pharmaceutical data services is shaped by superior industry experience. This deep experience enables i3 Statprobe to precisely pair proven processes and technology with client studies—from multinational Phase III trials with hybrid EDC architecture to niche studies for orphan drugs. As a result, i3 Statprobe helps streamline the route to more efficient and effective solutions.

    i3 Pharma Resourcing
    i3 Pharma Resourcing draws on a deep understanding of clinical trials to provide unmatched multinational clinical research staffing on either an individual or project team basis. Clients consistently comment on our outstanding customer service and high quality professionals. i3 Pharma Resourcing is a strong complement to i3’s array of research and development services. Its relationship to the i3 organization delivers industry expertise in leading clinical research and data and with offices in key regional markets around the globe, it provides national and multinational service to customers.

    i3 Pharma Informatics
    Combining unparalleled data assets, online tools, and scientific expertise, i3 Pharma Informatics helps customers make more rapid, informed decisions throughout development and commercialization by providing a clearer understanding of products’ market dynamics.

    Offering insight at all stages of the product lifecycle, i3 Pharma Informatics’ extensive suite of analytic tools and consulting services provides a better understanding of products in the market, the patients who use them and the physicians who prescribe them.

    At the core of i3 Pharma Informtics is one of the world’s largest health care databases containing de-identified patient-level information on millions of individuals from multiple health plans. Access to this data asset provides customers with answers to their most pressing product and market issues.

    Products include:

  • i3 Invision™ for Managed Markets—An online tool for an integrated view of medical claims and prescription drug data using highly customized metrics and filters to segment the market and more efficiently target customers and measure results.
  • i3 Invision™ Data Mart—Licensed access to a nexus of information that can support product and market analyses for greater understanding of and quicker response to shifting market forces.
  • i3 Aperio™—An online tool to identify signals that could indicate a drug’s potential safety issues at near-real time.
  • i3 CRAFT™—A clinical research assessment and feasibility tool that helps define the most efficient markets in which to conduct a trial.

    For more information, visit:

    Key Statistics

    Ownership: Private

    Web Site: i3 (Basking Ridge, New Jersey)

  • Company News
    PharmaNet, Inc./i3 (Basking Ridge, New Jersey) to Showcase Unified Brand at Drug Information Association 2012 6/20/2012 10:12:19 AM
    i3 (Basking Ridge, New Jersey) Acquires ChinaGate, Providing Customers with Greater, More Efficient Access to Chinese Market 5/19/2010 9:45:22 AM
    i3 (Basking Ridge, New Jersey) Innovus To Deliver More Than 40 Presentations At ISPOR 5/14/2010 2:23:43 PM
    i3 (Basking Ridge, New Jersey) Adds Appointments To Key Leadership Positions 1/13/2010 10:03:41 AM
    i3 (Basking Ridge, New Jersey) to Announce Expansion in Japan 6/26/2009 11:10:47 AM
    i3 (Basking Ridge, New Jersey) Explores Link Between Bipolar Disorder And Lipid Disorder At NCDEU 6/19/2009 10:40:15 AM
    i3 Spain Ranks In The Top Ten Best Workplaces In Spain 5/13/2009 3:04:15 PM
    i3 (Basking Ridge, New Jersey) Launches Clinical Informatics Solutions Group 4/20/2009 2:27:00 PM
    i3 (Basking Ridge, New Jersey) Launches New Web-Based Technology To Simplify And Accelerate The Clinical Trial Process 3/17/2009 2:44:01 PM
    i3 (Basking Ridge, New Jersey) Drug Safety to Deliver 17 Presentations at ICPE 2008 8/13/2008 11:24:55 AM